Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, NewAmsterdam Pharma Company NV’s stock clocked out at $16.76, up 3.08% from its previous closing price of $16.26. In other words, the price has increased by $3.08 from its previous closing price. On the day, 0.77 million shares were traded. NAMS stock price reached its highest trading level at $17.05 during the session, while it also had its lowest trading level at $15.79.
Ratios:
To gain a deeper understanding of NAMS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.83 and its Current Ratio is at 9.83. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On March 14, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $35.
On January 18, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $30.Guggenheim initiated its Buy rating on January 18, 2024, with a $30 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 20 ’24 when Davidson Michael H. bought 5,000 shares for $16.27 per share. The transaction valued at 81,350 led to the insider holds 209,784 shares of the business.
Davidson Michael H. bought 5,000 shares of NAMS for $86,308 on Jun 20 ’24. The Chief Executive Officer now owns 204,784 shares after completing the transaction at $17.26 per share. On Mar 26 ’24, another insider, Topper James N, who serves as the Director of the company, bought 8,429 shares for $21.50 each. As a result, the insider paid 181,224 and bolstered with 3,008,429 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NAMS now has a Market Capitalization of 1508658176 and an Enterprise Value of 1078511360. Its current Enterprise Value per Revenue stands at 145.274 whereas that against EBITDA is -5.17.
Stock Price History:
Over the past 52 weeks, NAMS has reached a high of $26.35, while it has fallen to a 52-week low of $5.63. The 50-Day Moving Average of the stock is -8.06%, while the 200-Day Moving Average is calculated to be -6.39%.
Shares Statistics:
It appears that NAMS traded 316.78K shares on average per day over the past three months and 617320 shares per day over the past ten days. A total of 82.47M shares are outstanding, with a floating share count of 39.19M. Insiders hold about 56.46% of the company’s shares, while institutions hold 37.50% stake in the company. Shares short for NAMS as of 1722384000 were 1399537 with a Short Ratio of 4.42, compared to 1719532800 on 220754. Therefore, it implies a Short% of Shares Outstanding of 1399537 and a Short% of Float of 2.6300002.
